IMMUNE PHARMACEUTICALS INC 4
4 · IMMUNE PHARMACEUTICALS INC · Filed Feb 5, 2014
Insider Transaction Report
Form 4
Cook Robert W.
CFO-SVP- Finance & Admin.
Transactions
- Award
stock options (right to buy)
2014-02-03+100,000→ 100,000 totalExercise: $2.38Exp: 2024-02-02→ common stock (100,000 underlying)
Footnotes (1)
- [F1]The options become exercisable in four quarterly increments over the first year from the grant date.